The Oxford-AstraZeneca vaccine is best suited for Africa according to Professor of Vaccinology at the University of the Witwatersrand, Shabir Madhi.
Professor Madhi is leading the clinical trial of the vaccine locally.
He said the vaccine isn’t only effective but also affordable.
The Oxford vaccine is so far reported to have a good safety record with no serious side-effects.
The ongoing late-stage trial is taking place at 150 global sites in the US, Germany, Turkey, South Africa, Brazil and Argentina.
More Stories
Dut And Lenovo Launches Robogirl 2022 To Train Young Female Learners On Coding And Robotics
EFF To Open Racial Discrimination Case With HRC Following Racist CT Pub Incident
NEC Resolves For Ramaphosa To Remain ANC President
Mabuza Implicated In R35bn Land Claim Scam
Parts Of Joburg Without Power After Severe Storms
MPs Vote To Move Phala Phala Debate To Next Week
Ramaphosa Will Not Resign, Spokesperson Says
Majodina Says There’s No Reason To Panic
ANC NEC To Meet Again On Phala Phala
Stage 2 Blackouts From 4pm
ANC NEC To Have Emergency Meeting
Mantashe Trashes Phala Phala Report